BAC

Bank of America Corporation

60
Fundamentals72/ 100
Valuation55/ 100
Upside potential71/ 100
Risk potential10/ 100

BAC has lower modeled downside risk, despite its lower overall score.

TSM

Taiwan Semiconductor Manufacturing Company Limited

76
Fundamentals92/ 100
Valuation50/ 100
Upside potential59/ 100
Risk potential18/ 100

TSM has the edge over BAC overall, supported by stronger fundamentals.

BAC Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.

TSM Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Strong

TSM's balance sheet is currently strong. There isn't enough data to rate its revenue, profitability and cash flow.

BAC PE Valuation

CHEAPFAIREXPENSIVE5.6x11x17x22x
CHEAPFAIREXPENSIVE5.6x11x17x22x
LevelPEPriceVs current
Cheap9.4x$39.50-22%
Forward10x$50.51—
Current12x$50.51—
Fair13x$53.81+6.5%
Expensive15x$62.23+23%

Historical ranges are pointers, not guarantees.

BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.

TSM PE Valuation

TSM has no meaningful PE right now: it lost money over the past year.

BAC Forward outlook

MetricOutlook
Improving
Growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for BAC, with profitability improving.

TSM Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for TSM, with profitability improving.

BAC Risk to reward

ScenarioChangePrice
Upside+25%$63.36
Downside-10%$45.36

Calculated from the latest close: $50.51 on Nov 12.

BAC has a better modeled risk to reward balance than TSM, with less potential downside for the same potential upside.

TSM Risk to reward

ScenarioChangePrice
Upside+25%$508.50
Downside-18%$334.36

Calculated from the latest close: $405.49 on Nov 12.

TSM trails BAC on modeled risk to reward, with more potential downside for the same potential upside.

BAC Earnings Per Share

Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
QuarterTTM EPSYoY
Forward$4.92+17%
Q3 2026$4.19+14%
Q2 2026$4.34+27%
Q1 2026$4.02+20%
Q4 2025$3.81+19%
Q3 2025$3.66+33%
Q2 2025$3.41+20%
Q1 2025$3.35+16%
Q4 2024$3.21+4.2%

BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.

TSM Earnings Per Share

TSM and BAC do not have enough comparable growth data to identify a winner.

BAC Quarterly Revenue

Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
QuarterRevenueYoY
Q3 2026$30B+6.7%
Q2 2026$31.6B+19%
Q1 2026$30.3B+11%
Q4 2025$31.2B+23%
Q3 2025$28.1B+11%
Q2 2025$26.5B+4.3%
Q1 2025$27.4B+6%
Q4 2024$25.3B+15%

BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.

TSM Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

TSM and BAC do not have enough comparable growth data to identify a winner.

BAC Free Cash Flow

Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
QuarterFree cash flowYoY
Q3 2026-$6.5B-114%
Q2 2026$29B+$38.2B
Q1 2026$41.8B+$44B
Q4 2025-$22.9B-189%
Q3 2025$46.9B+$84.2B
Q2 2025-$9.1B-150%
Q1 2025-$2.2B+$13.4B
Q4 2024$25.9B-21%

BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.

TSM Free Cash Flow

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

TSM and BAC do not have enough comparable growth data to identify a winner.

BAC Total Shares

Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
PeriodChange %Net change
Quarterly-1%-72M shares
1 year-5.3%-405M shares
3 years-11%-854M shares
5 years-15%-1.3B shares
Available history-24%-2.2B shares

BAC has the edge over TSM on shareholder dilution, with a more favorable share count trend.

TSM Total Shares

Q4 2023: 5.2BQ1 2024: 5.2BQ2 2024: 5.2BQ3 2024: 5.2BQ4 2024: 5.2BQ1 2025: 5.2BQ2 2025: 5.2BQ3 2025: 5.2BQ4 2025: 5.2BQ1 2026: 5.2BQ2 2026: 5.2BQ3 2026: 5.2B
Q4 2023: 5.2BQ1 2024: 5.2BQ2 2024: 5.2BQ3 2024: 5.2BQ4 2024: 5.2BQ1 2025: 5.2BQ2 2025: 5.2BQ3 2025: 5.2BQ4 2025: 5.2BQ1 2026: 5.2BQ2 2026: 5.2BQ3 2026: 5.2B
PeriodChange %Net change
Quarterly0%+45.8K shares
1 year0%+391K shares
3 years0%+528K shares
5 years0%+324K shares
Available history0%+324K shares

TSM has 5.2B diluted shares, about the same as a year ago.

BAC Net Leverage

Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
QuarterNet LeverageStatus
Q3 20266.4xHigh
Q2 20266.7xHigh
Q1 20267.1xHigh
Q4 20257.7xHigh
Q3 20258.3xHigh
Q2 20258.8xHigh
Q1 20258.6xHigh
Q4 20249.0xHigh

BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.

TSM Net Leverage

Q4 2023: -0.3xQ1 2024: -0.4xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.5xQ1 2025: -0.6xQ2 2025: -0.6xQ3 2025: -0.6xQ4 2025: -0.6xQ1 2026: -0.7xQ2 2026: -0.6xQ3 2026: -0.7x
Q4 2023: -0.3xQ1 2024: -0.4xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.5xQ1 2025: -0.6xQ2 2025: -0.6xQ3 2025: -0.6xQ4 2025: -0.6xQ1 2026: -0.7xQ2 2026: -0.6xQ3 2026: -0.7x
QuarterNet LeverageStatus
Q3 2026-0.7xNet Cash
Q2 2026-0.6xNet Cash
Q1 2026-0.7xNet Cash
Q4 2025-0.6xNet Cash
Q3 2025-0.6xNet Cash
Q2 2025-0.6xNet Cash
Q1 2025-0.6xNet Cash
Q4 2024-0.5xNet Cash

TSM has the edge over BAC on leverage, with a lower net debt burden relative to earnings.

BAC Weekly Momentum

MetricValueStatus
RSI37.1Neutral
Stochastic4.9Oversold

BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).

TSM Weekly Momentum

MetricValueStatus
RSI48.8Neutral
Stochastic28.9Neutral

TSM's weekly RSI is 49 (neutral) and its Stochastic is 29 (neutral).

BAC PE vs Financial Services Sector

MetricBACSector medianRelative
PE12x13x7.5% below
PE %406323 pts below

BAC has the edge over TSM on valuation relative to its sector.

TSM PE vs Technology Sector

MetricTSMSector medianRelative
PE27x28x3.3% below
PE %453510 pts above

TSM has no meaningful PE right now: it lost money over the past year.

BAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$52.13% below
20 week MA$57.813% below
50 week MA$54.77.7% below
100 week MA$50.50% below
200 week MA$42.519% above

BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.

TSM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$424.44.4% below
20 week MA$422.44% below
50 week MA$386.54.9% above
100 week MA$304.533% above
200 week MA$215.688% above

TSM has the edge over BAC on trend strength, trading above more of its moving averages.

BAC Yearly ROI

YearStart priceEnd priceROI
2020$35.4$30.0-15%
2021$30.0$44.4+48%
2022$44.4$32.5-27%
2023$32.5$33.7+3.7%
2024$33.7$44.3+32%
2025$44.3$56.2+27%
2026 YTD$56.2$50.5-10%

BAC has finished higher in four of the last six years. It's down 10% so far in 2026.

TSM Yearly ROI

YearStart priceEnd priceROI
2020$58.5$106.0+81%
2021$106.0$120.7+14%
2022$120.7$74.9-38%
2023$74.9$104.0+39%
2024$104.0$201.6+94%
2025$201.6$302.8+50%
2026 YTD$302.8$405.5+34%

TSM has the edge over BAC on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key